Literature DB >> 11049769

Cluster of pulmonary infections caused by Cunninghamella bertholletiae in immunocompromised patients.

V Rickerts1, A Böhme, A Viertel, G Behrendt, V Jacobi, K Tintelnot, G Just-Nübling.   

Abstract

Cunninghamella bertholletiae is a rare cause of pulmonary mucormycosis. We describe a cluster of invasive pulmonary infections caused by C. bertholletiae in 4 immunocompromised patients that occurred during a 2-year period at 1 center. Three of the patients were receiving antifungal prophylaxis with itraconazole. Presenting symptoms were fever unresponsive to antibacterial chemotherapy, hemoptysis, and infiltrates on chest radiograms. Three patients were treated with liposomal amphotericin B. Only 1 patient survived.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11049769     DOI: 10.1086/318144

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  18 in total

1.  Posaconazole as salvage therapy for zygomycosis.

Authors:  R N Greenberg; K Mullane; J-A H van Burik; I Raad; M J Abzug; G Anstead; R Herbrecht; A Langston; K A Marr; G Schiller; M Schuster; J R Wingard; C E Gonzalez; S G Revankar; G Corcoran; R J Kryscio; R Hare
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

2.  Diagnosis of invasive aspergillosis and mucormycosis in immunocompromised patients by seminested PCR assay of tissue samples.

Authors:  V Rickerts; G Just-Nübling; F Konrad; J Kern; E Lambrecht; A Böhme; V Jacobi; R Bialek
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-01       Impact factor: 3.267

Review 3.  Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species.

Authors:  Marisa Z R Gomes; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

4.  PCR based identification and discrimination of agents of mucormycosis and aspergillosis in paraffin wax embedded tissue.

Authors:  R Bialek; F Konrad; J Kern; C Aepinus; L Cecenas; G M Gonzalez; G Just-Nübling; B Willinger; E Presterl; C Lass-Flörl; V Rickerts
Journal:  J Clin Pathol       Date:  2005-11       Impact factor: 3.411

Review 5.  Zygomycosis: the re-emerging fungal infection.

Authors:  M Chayakulkeeree; M A Ghannoum; J R Perfect
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-04       Impact factor: 3.267

6.  A 29-year-old man with hospital-acquired cavitary pneumonia.

Authors:  Mansoor Mehmood; Ruba A Halloush; Faisal A Khasawneh
Journal:  Can Respir J       Date:  2014-04-07       Impact factor: 2.409

7.  Nosocomial invasive infection caused by Cunninghamella bertholletiae: case report.

Authors:  Xisto Sena Passos; Werther Souza Sales; Patrícia Jackeline Maciel; Carolina Rodrigues Costa; Denise Milioli Ferreira; Maria Rosário Rodrigues do Silva
Journal:  Mycopathologia       Date:  2006-01       Impact factor: 2.574

8.  Mucormycosis in immunochallenged patients.

Authors:  Jane Pak; Veronica T Tucci; Albert L Vincent; Ramon L Sandin; John N Greene
Journal:  J Emerg Trauma Shock       Date:  2008-07

Review 9.  Disseminated zygomycosis caused by Cunninghamella bertholletiae in patient with hematological malignancy and review of published case reports.

Authors:  Tsung-Ting Hsieh; Hsiang-Kuang Tseng; Pei-Lun Sun; Yu-Hung Wu; Gon-Shen Chen
Journal:  Mycopathologia       Date:  2012-11-04       Impact factor: 2.574

10.  Successful Treatment of Pulmonary Mucormycosis Caused by Cunninghamella bertholletiae with High-Dose Liposomal Amphotericin B (10 mg/kg/day) Followed by a Lobectomy in Cord Blood Transplant Recipients.

Authors:  Hikari Ota; Hisashi Yamamoto; Muneyoshi Kimura; Hideki Araoka; Takeshi Fujii; Takashi Umeyama; Hideaki Ohno; Yoshitsugu Miyazaki; Daisuke Kaji; Yuki Taya; Aya Nishida; Kazuya Ishiwata; Masanori Tsuji; Shinsuke Takagi; Yuki Asano-Mori; Go Yamamoto; Naoyuki Uchida; Koji Izutsu; Kazuhiro Masuoka; Atsushi Wake; Akiko Yoneyama; Shigeyoshi Makino; Shuichi Taniguchi
Journal:  Mycopathologia       Date:  2017-06-02       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.